List of insiders holdings for Janux Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2025-06-13 19:33:08 | 0 11,207,610 | 11,207,610 | Form 4 |
| 2 | Lichter Jay 10% Owner | 2024-10-24 16:15:07 | 64,436 6,553,816 | 6,618,252 | Form 4 |
| 3 | Reardon Tighe Acting Chief Financial Officer | 2024-06-05 19:23:19 | 174,989 3,340,018 | 3,515,007 | Form 4 |
| 4 | Bregua Corp 10% Owner | 2024-11-04 16:05:27 | 2,999,990 0 | 2,999,990 | Form 13G |
| 5 | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 2024-11-08 17:58:50 | 2,146,482 0 | 2,146,482 | Form 13D |
| 6 | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director | 2024-08-09 16:09:57 | 1,965,266 0 | 1,965,266 | Form 13D |
| 7 | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 2024-08-09 16:09:57 | 1,965,266 0 | 1,965,266 | Form 13D |
| 8 | Campbell David Alan President and CEO | 2025-01-08 20:00:05 | 293,054 0 | 293,054 | Form 4 |
| 9 | DiRaimondo Thomas Chief Scientific Officer | 2025-01-03 20:10:06 | 213,719 0 | 213,719 | Form 4 |
| 10 | Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr | 2025-06-04 20:00:20 | 198,000 0 | 198,000 | Form 4 |
| 11 | Meyer Andrew Hollman Chief Business Officer | 2025-05-02 20:00:06 | 169,471 0 | 169,471 | Form 4 |
| 12 | Winter Charles M. Chief Technical Officer | 2025-01-03 20:10:12 | 157,788 0 | 157,788 | Form 4 |
| 13 | Gujrathi Sheila Director | 2025-06-13 19:30:17 | 130,556 0 | 130,556 | Form 4 |
| 14 | Robinson Byron Chief Strategy Officer | 2025-01-03 20:10:08 | 126,000 0 | 126,000 | Form 4 |
| 15 | McIver Zachariah Chief Medical Officer | 2025-01-03 20:10:13 | 117,000 0 | 117,000 | Form 4 |
| 16 | Salek-Ardakani Shahram Chief Scientific Officer | 2022-01-05 17:28:46 | 114,250 0 | 114,250 | Form 4 |
| 17 | Godfrey Wayne Chief Medical Officer | 2023-01-05 16:32:07 | 110,000 0 | 110,000 | Form 4 |
| 18 | CAPPS VICKIE L Director | 2025-06-13 19:30:19 | 85,765 0 | 85,765 | Form 4 |
| 19 | Dobek Maria Vice President, Accounting | 2025-01-03 20:10:04 | 45,501 0 | 45,501 | Form 4 |
| 20 | DOBMEIER ERIC Director | 2025-06-13 19:30:18 | 21,648 0 | 21,648 | Form 4 |
| 21 | Hernday Natasha Director | 2025-06-13 19:30:15 | 20,398 0 | 20,398 | Form 4 |
| 22 | Kung Winston Director | 2025-06-13 19:30:06 | 17,917 0 | 17,917 | Form 4 |
| 23 | Simson Jake Director | 2025-06-13 19:30:11 | 17,917 0 | 17,917 | Form 4 |
| 24 | McNulty Alana B. Director | 2025-06-13 19:30:14 | 17,917 0 | 17,917 | Form 4 |
| 25 | Barrett Ronald W Director | 2025-06-13 19:30:20 | 17,917 0 | 17,917 | Form 4 |
| 26 | Heller Stefan Director | 2022-06-16 16:33:52 | 12,500 0 | 12,500 | Form 4 |
| 27 | Thompson Peter A. Director | 2022-06-16 16:35:01 | 12,500 0 | 12,500 | Form 4 |